Status:
COMPLETED
Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Parkinson Disease
Eligibility:
All Genders
30-75 years
Brief Summary
The purpose is to explore the frequency of impulse control disorders in Parkinson's patients treated with different Parkinson's medications.
Eligibility Criteria
Inclusion
- Observation Criteria:
- Male or female outpatients, aged 30 to 75 years of age, with idiopathic PD. Patients must be selected on the basis of a prospective recruitment plan documented at the site, with the objective of obtaining an unbiased representative sample.
- Patients must have been treated with anti-parkinson medication for a period of one year or greater and demonstrated a treatment response, in the opinion of the Investigator.
- Patients must be willing and able to comply with study procedures. Patients must be willing and able to give meaningful, written informed consent. This must be completed prior to beginning any study procedures, in accordance with GCP and local legislation.
Exclusion
Key Trial Info
Start Date :
September 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
3234 Patients enrolled
Trial Details
Trial ID
NCT00617019
Start Date
September 1 2006
Last Update
November 13 2013
Active Locations (49)
Enter a location and click search to find clinical trials sorted by distance.
1
248.619.01034 Neurological Physicians of Arizona
Gilbert, Arizona, United States
2
248.619.01007 Mayo Clinic - Scottsdale
Scottsdale, Arizona, United States
3
248.619.01025 Sun Health Research Institute
Sun City, Arizona, United States
4
248.619.01018 Margolin Brain Institute
Fresno, California, United States